About
Lygenesis is a clinical-stage cell therapy company developing treatments that use a patient's lymph nodes as bioreactors to grow functioning ectopic organs to address conditions like end stage liver disease and type 1 diabetes.
Explore Lygenesis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.